DMAC

DiaMedica Therapeutics Inc.

Price

$6.65

return (12m)

25.47%

p/e

-9.31

p/bv

9.11

DIVIDEND YIELD

0.00%

DMAC price

DiaMedica Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DMAC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.60%

3 months

17.91%

1 year

25.47%

2 years

70.95%

5 years

58.33%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals DMAC

Valuation

P/E

-9.31

Sector -4.23

Industry -4.23

P/BV

9.11

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

Sector -51.33

Industry -51.33

P/EBIT

Sector -39.56

Industry -39.56

P/Total Assets

7.76

Sector 1.25

Industry 1.25

P/Net Current Assets

9.28

Sector -5.36

Industry -5.36

P/Working Capital

9.26

Sector -1.24

Industry -1.24

EPS

-0.70

Sector -1.92

Industry -1.92

BVPS

0.71

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

0.00%

Sector 39.10%

Industry 39.10%

EBITDA Margin

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

0.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

0.00%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-97.91%

Sector -60.49%

Industry -60.49%

ROA

-83.42%

Sector -63.06%

Industry -63.06%

ROIC

0.00%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.72

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.85

Sector 0.43

Industry 0.43

Liabilities/Assets

0.15

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

22.53%

Sector -

Industry -

Fundamentals DMAC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DMAC DiaMedica Therapeutics Inc.	$6.65	25.00%	0.00%	-9.31	9.11	-97.91%	0.00%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DMAC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT DiaMedica Therapeutics

DiaMedica Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

26 years

Founded: 2000

2007

Time since IPO - 19 years

9

Employees

DiaMedica Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $349.38 million, with shareholders equity totaling $38.34 million.

The company employs approximately 9 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, DiaMedica Therapeutics Inc. reported $- in revenue, generating net income of $-37.54 million.

Key financial metrics include a P/E ratio of -9.31, a price-to-book (P/B) ratio of 9.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DMAC.

Market cap

$349.38 million

Net worth

$38.34 million

$38,340,000.00

Assets

$45.00 million

$45,000,000.00

Total Shares Outstanding

54.00 million

54,000,000

Average Daily Trading Volume

$197.86 Thousand

$197,862.00

Sector

Health Care

Industry

Biotechnology

DMAC

DMAC revenue and profits

Financial Results DMAC

DRAG THE FRAME TO SEE MORE DATA

DMAC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of DiaMedica Therapeutics (DMAC) today?

A cotação de DiaMedica Therapeutics (DMAC) hoje está em US$ 6.65, com uma variação de 25.47% em relação ao último ano. A cotação de DiaMedica Therapeutics (DMAC) iniciou o ano negociando na casa dos US$ 7.96 e hoje está em US$ 6.65. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de DiaMedica Therapeutics (DMAC) e dados de ações do Ibovespa e mercados internacionais.

Quando DiaMedica Therapeutics (DMAC) paga dividendos?

DiaMedica Therapeutics (DMAC) não distribuiu dividendos no último ano.

Is DiaMedica Therapeutics (DMAC) a good investment?

Atualmente, DiaMedica Therapeutics (DMAC) está cotada a US$ 6.65, com um P/L de -9.31, representando um desvio de -801% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 25.47 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 25.47%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy DiaMedica Therapeutics (DMAC) stock?

Investir em ações de DiaMedica Therapeutics (DMAC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of DiaMedica Therapeutics (DMAC) yield today?

A rentabilidade de DiaMedica Therapeutics (DMAC) foi de -0.60% no último mês, 25.47% no último ano e 58.33% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de DiaMedica Therapeutics (DMAC) hoje, o investimento total seria de US$ 665.00, com base na cotação atual de US$ 6.65.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 834.38
Em 5 anos: US$ 1,052.89
Em 10 anos: US$ 665.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

DMAC

DiaMedica Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment DMAC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING DMAC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT DiaMedica Therapeutics

DiaMedica Therapeutics Inc.

United States

26 years

2007

9

PROFIT X PRICE DMAC

Financial Results DMAC

DMAC cash flow

Asset, Revenue and Profit Growth - DMAC

DMAC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions